fda warning bpc-157 compounding safety risks Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA panel narrowly backs unapproved

FDA panel narrowly backs unapproved peptide drugs NBC4 Washington An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with fda warning bpc 157 unapproved new drug The FDA has issued clear signals on BPC 157 The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link

SKU: 44970803016 · From iglepidom.org